Depatuxizumab MMAE
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Bioactivity
Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising the anti-EGFR monoclonal antibody depatuxizumab linked to the cytotoxic agent monomethyl auristatin E (MMAE) . This ADC effectively suppresses the growth of xenograft models harboring both mutant EGFRvIII and wild-type EGFR [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1461487-01 0.02 mg (E-Coli)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details MBS1461487-02 0.1 mg (E-Coli)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details 
MBS1461487-03 0.02 mg (Yeast)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details MBS1461487-04 0.1 mg (Yeast)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details 
MBS1461487-05 0.02 mg (Baculovirus)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details MBS1461487-06 0.02 mg (Mammalian-Cell)
Recombinant Antirrhinum hispanicum Ribonuclease S-2 (S2)
Sign In for Pricing
View Details